How many insider declarations has Giordano Christopher Thomas filed?

Giordano Christopher Thomas has filed 3 public insider declarations with SEC (Form 4).

What is Giordano Christopher Thomas's role?

Giordano Christopher Thomas's reported role is not specified by the regulator across the filings.

Which companies does Giordano Christopher Thomas report trades for?

Giordano Christopher Thomas reports trades for Tenax Therapeutics, INC..

What is Giordano Christopher Thomas's declared buy vs sell volume?

Across the available history, declared buys total 11k€ and disposals 0.

← Executives ★ Sign in to follow

GC

Giordano Christopher Thomas

CEOM

·SEC (Form 4)

Tenax Therapeutics, INC.

Cumul. flow

0

Total declarations

0

Company

€10,785

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+52.5%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the detailed record of transactions filed by Giordano Christopher Thomas. Officer active across 1 company, notably Tenax Therapeutics, INC.. Cumulatively, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €11k. Activity tracked since 18 November 2025. The latest transaction was disclosed on 13 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Giordano Christopher Thomas

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Tenax Therapeutics, INC. (US)

Declarations3 total

◇

Giordano Christopher Thomas

CEOExecutives13 Jul 2026Tenax Therapeutics, INC.

$77729SEC ↗

219 shares@ US$3.5490.0011% mcap1.2% of flowCommon StockSEC:0001193125-26-303600:0

◇

Giordano Christopher Thomas

CEOExecutives13 Jul 2026Tenax Therapeutics, INC.

$50,49039SEC ↗

8,500 shares@ US$5.940.073% mcap79.4% of flowCommon StockSEC:0001193125-26-303600:1

▲

Giordano Christopher Thomas

CEOExecutives18 Nov 2025Tenax Therapeutics, INC.

$12,50049SEC ↗

1,612 shares@ US$7.7546100.0% of flowCommon StockSEC:0001871714-25-000002:0

Canonical exit: 16 Feb 2026 (T+90)

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

GC

Giordano Christopher Thomas

CEOM

·SEC (Form 4)

Tenax Therapeutics, INC.

Cumul. flow

0

Total declarations

0

Company

€10,785

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+52.5%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the detailed record of transactions filed by Giordano Christopher Thomas. Officer active across 1 company, notably Tenax Therapeutics, INC.. Cumulatively, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €11k. Activity tracked since 18 November 2025. The latest transaction was disclosed on 13 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.